APO RESEARCH · REPORT
Rhodiola Rosea P.E.
Rhodiola rosea (commonly golden root, rose root, roseroot, western roseroot, Aaron's rod, Arctic root, king's crown, lignum rhodium, orpin rose) is a perennial flowering plant in the family Crassulaceae.
Product & engineering
Understand the product.
Rhodiola rosea (commonly golden root, rose root, roseroot, western roseroot, Aaron's rod, Arctic root, king's crown, lignum rhodium, orpin rose) is a perennial flowering plant in the family Crassulaceae.
Rhodiola rosea P.E. is derived from the root and rhizome of Rhodiola rosea. It has been traditionally used as a rare Chinese medicinal herb, and it has also been applied in Tibetan medicine.
Since the 1970s, the natural stocks of rhodiola rosea are continuously diminishing as a result of unregulated collection. According to the Red List, the plant is severely endangered and even threatened by extinction. Rhodiola rosea has been on the list of the rare plants of Siberia since 1980 and the plant needs government protection.
In the face of declining availability of the natural supply, rhodiola rosea P.E. will continue in the state that production behind demand. And the price will continue to rise for some time.
Selected research
Market Structure
Global Rhodiola Rosea P.E. Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Rhodiola rosea (commonly golden root, rose root, roseroot, western roseroot, Aaron's rod, Arctic root, king's crown, lignum rhodium, orpin rose) is a perennial flowering plant in the family Crassulaceae.
Rhodiola rosea P.E. is derived from the root and rhizome of Rhodiola rosea. It has been traditionally used as a rare Chinese medicinal herb, and it has also been applied in Tibetan medicine.
Since the 1970s, the natural stocks of rhodiola rosea are continuously diminishing as a result of unregulated collection. According to the Red List, the plant is severely endangered and even threatened by extinction. Rhodiola rosea has been on the list of the rare plants of Siberia since 1980 and the plant needs government protection.
Read the full market overview
In the face of declining availability of the natural supply, rhodiola rosea P.E. will continue in the state that production behind demand. And the price will continue to rise for some time.
At present, the major manufacturers of rhodiola rosea P.E. are Layn, Huisong Pharmaceuticals, Jinrui Natural Ingredients, Skyherb, Martin Bauer Group, etc. The top four companies occupied 27% of the total amount.
China is the dominate producer and exporter of rhodiola rosea P.E., with the production market share of 74%.
The report provides an overview of the global Rhodiola Rosea P.E. market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Rhodiola Rosea P.E. and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Rhodiola Rosea P.E. sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rhodiola Rosea P.E. market size, projected growth trends, production technologies, key applications, and end-use industries.
Rhodiola Rosea P.E. Segment by Company
Layn
Martin Bauer Group
Skyherb
Acetar Bio-Tech
Shaanxi Jintai
Gansu Xinhuikang
Bioland
Jinrui Natural Ingredients
Anhui Kunda Biological
Wagott
Huisong Pharmaceuticals
Xi'an GreenMan
Yuensun Biological Technology
Xi'an Hao Tian
Xi'an Gaoyuan
Rhodiola Rosea P.E. Segment by Type
Rosavin
Salidroside
Rhodiola Rosea P.E. Segment by Application
Cosmetics
Health Care Products
Pharmaceuticals
Others
Rhodiola Rosea P.E. Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rhodiola Rosea P.E. market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rhodiola Rosea P.E. and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rhodiola Rosea P.E..
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Rhodiola Rosea P.E. market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rhodiola Rosea P.E. industry.
Chapter 3: Detailed analysis of Rhodiola Rosea P.E. market competition landscape. Including Rhodiola Rosea P.E. manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Rhodiola Rosea P.E. by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Rhodiola Rosea P.E. in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Rosavin
- Salidroside
Applications
- Cosmetics
- Health Care Products
- Pharmaceuticals
- Others
Companies covered
- Layn
- Martin Bauer Group
- Skyherb
- Acetar Bio-Tech
- Shaanxi Jintai
- Gansu Xinhuikang
- Bioland
- Jinrui Natural Ingredients
- Anhui Kunda Biological
- Wagott
- Huisong Pharmaceuticals
- Xi'an GreenMan
- Yuensun Biological Technology
- Xi'an Hao Tian
- Xi'an Gaoyuan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Rhodiola Rosea P.E. Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Rhodiola Rosea P.E. Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Rhodiola Rosea P.E. Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Rhodiola Rosea P.E. Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Rhodiola Rosea P.E. Market Dynamics
- 2.1 Rhodiola Rosea P.E. Industry Trends
- 2.2 Rhodiola Rosea P.E. Industry Drivers
- 2.3 Rhodiola Rosea P.E. Industry Opportunities and Challenges
- 2.4 Rhodiola Rosea P.E. Industry Restraints
3 Rhodiola Rosea P.E. Market by Manufacturers
- 3.1 Global Rhodiola Rosea P.E. Production Value by Manufacturers (2021-2026)
- 3.2 Global Rhodiola Rosea P.E. Production by Manufacturers (2021-2026)
- 3.3 Global Rhodiola Rosea P.E. Average Price by Manufacturers (2021-2026)
- 3.4 Global Rhodiola Rosea P.E. Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Rhodiola Rosea P.E. Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Rhodiola Rosea P.E. Manufacturers, Product Type & Application
- 3.7 Global Rhodiola Rosea P.E. Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Rhodiola Rosea P.E. Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Rhodiola Rosea P.E. Players Market Share by Production Value in 2025
- 3.8.3 2025 Rhodiola Rosea P.E. Tier 1, Tier 2, and Tier 3
4 Rhodiola Rosea P.E. Market by Type
- 4.1 Rhodiola Rosea P.E. Type Introduction
- 4.1.1 Rosavin
- 4.1.2 Salidroside
- 4.2 Global Rhodiola Rosea P.E. Production by Type
- 4.2.1 Global Rhodiola Rosea P.E. Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Rhodiola Rosea P.E. Production by Type (2021-2032)
- 4.2.3 Global Rhodiola Rosea P.E. Production Market Share by Type (2021-2032)
- 4.3 Global Rhodiola Rosea P.E. Production Value by Type
- 4.3.1 Global Rhodiola Rosea P.E. Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Rhodiola Rosea P.E. Production Value by Type (2021-2032)
- 4.3.3 Global Rhodiola Rosea P.E. Production Value Market Share by Type (2021-2032)
5 Rhodiola Rosea P.E. Market by Application
- 5.1 Rhodiola Rosea P.E. Application Introduction
- 5.1.1 Cosmetics
- 5.1.2 Health Care Products
- 5.1.3 Pharmaceuticals
- 5.1.4 Others
- 5.2 Global Rhodiola Rosea P.E. Production by Application
- 5.2.1 Global Rhodiola Rosea P.E. Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Rhodiola Rosea P.E. Production by Application (2021-2032)
- 5.2.3 Global Rhodiola Rosea P.E. Production Market Share by Application (2021-2032)
- 5.3 Global Rhodiola Rosea P.E. Production Value by Application
- 5.3.1 Global Rhodiola Rosea P.E. Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Rhodiola Rosea P.E. Production Value by Application (2021-2032)
- 5.3.3 Global Rhodiola Rosea P.E. Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Layn
- 6.1.1 Layn Company Information
- 6.1.2 Layn Business Overview
- 6.1.3 Layn Rhodiola Rosea P.E. Production, Value and Gross Margin (2021-2026)
- 6.1.4 Layn Rhodiola Rosea P.E. Product Portfolio
- 6.1.5 Layn Recent Developments
- 6.2 Martin Bauer Group
- 6.2.1 Martin Bauer Group Company Information
- 6.2.2 Martin Bauer Group Business Overview
- 6.2.3 Martin Bauer Group Rhodiola Rosea P.E. Production, Value and Gross Margin (2021-2026)
- 6.2.4 Martin Bauer Group Rhodiola Rosea P.E. Product Portfolio
- 6.2.5 Martin Bauer Group Recent Developments
- 6.3 Skyherb
- 6.3.1 Skyherb Company Information
- 6.3.2 Skyherb Business Overview
- 6.3.3 Skyherb Rhodiola Rosea P.E. Production, Value and Gross Margin (2021-2026)
- 6.3.4 Skyherb Rhodiola Rosea P.E. Product Portfolio
- 6.3.5 Skyherb Recent Developments
- 6.4 Acetar Bio-Tech
- 6.4.1 Acetar Bio-Tech Company Information
- 6.4.2 Acetar Bio-Tech Business Overview
- 6.4.3 Acetar Bio-Tech Rhodiola Rosea P.E. Production, Value and Gross Margin (2021-2026)
- 6.4.4 Acetar Bio-Tech Rhodiola Rosea P.E. Product Portfolio
- 6.4.5 Acetar Bio-Tech Recent Developments
- 6.5 Shaanxi Jintai
- 6.5.1 Shaanxi Jintai Company Information
- 6.5.2 Shaanxi Jintai Business Overview
- 6.5.3 Shaanxi Jintai Rhodiola Rosea P.E. Production, Value and Gross Margin (2021-2026)
- 6.5.4 Shaanxi Jintai Rhodiola Rosea P.E. Product Portfolio
- 6.5.5 Shaanxi Jintai Recent Developments
- 6.6 Gansu Xinhuikang
- 6.6.1 Gansu Xinhuikang Company Information
- 6.6.2 Gansu Xinhuikang Business Overview
- 6.6.3 Gansu Xinhuikang Rhodiola Rosea P.E. Production, Value and Gross Margin (2021-2026)
- 6.6.4 Gansu Xinhuikang Rhodiola Rosea P.E. Product Portfolio
- 6.6.5 Gansu Xinhuikang Recent Developments
- 6.7 Bioland
- 6.7.1 Bioland Company Information
- 6.7.2 Bioland Business Overview
- 6.7.3 Bioland Rhodiola Rosea P.E. Production, Value and Gross Margin (2021-2026)
- 6.7.4 Bioland Rhodiola Rosea P.E. Product Portfolio
- 6.7.5 Bioland Recent Developments
- 6.8 Jinrui Natural Ingredients
- 6.8.1 Jinrui Natural Ingredients Company Information
- 6.8.2 Jinrui Natural Ingredients Business Overview
- 6.8.3 Jinrui Natural Ingredients Rhodiola Rosea P.E. Production, Value and Gross Margin (2021-2026)
- 6.8.4 Jinrui Natural Ingredients Rhodiola Rosea P.E. Product Portfolio
- 6.8.5 Jinrui Natural Ingredients Recent Developments
- 6.9 Anhui Kunda Biological
- 6.9.1 Anhui Kunda Biological Company Information
- 6.9.2 Anhui Kunda Biological Business Overview
- 6.9.3 Anhui Kunda Biological Rhodiola Rosea P.E. Production, Value and Gross Margin (2021-2026)
- 6.9.4 Anhui Kunda Biological Rhodiola Rosea P.E. Product Portfolio
- 6.9.5 Anhui Kunda Biological Recent Developments
- 6.10 Wagott
- 6.10.1 Wagott Company Information
- 6.10.2 Wagott Business Overview
- 6.10.3 Wagott Rhodiola Rosea P.E. Production, Value and Gross Margin (2021-2026)
- 6.10.4 Wagott Rhodiola Rosea P.E. Product Portfolio
- 6.10.5 Wagott Recent Developments
- 6.11 Huisong Pharmaceuticals
- 6.11.1 Huisong Pharmaceuticals Company Information
- 6.11.2 Huisong Pharmaceuticals Business Overview
- 6.11.3 Huisong Pharmaceuticals Rhodiola Rosea P.E. Production, Value and Gross Margin (2021-2026)
- 6.11.4 Huisong Pharmaceuticals Rhodiola Rosea P.E. Product Portfolio
- 6.11.5 Huisong Pharmaceuticals Recent Developments
- 6.12 Xi'an GreenMan
- 6.12.1 Xi'an GreenMan Company Information
- 6.12.2 Xi'an GreenMan Business Overview
- 6.12.3 Xi'an GreenMan Rhodiola Rosea P.E. Production, Value and Gross Margin (2021-2026)
- 6.12.4 Xi'an GreenMan Rhodiola Rosea P.E. Product Portfolio
- 6.12.5 Xi'an GreenMan Recent Developments
- 6.13 Yuensun Biological Technology
- 6.13.1 Yuensun Biological Technology Company Information
- 6.13.2 Yuensun Biological Technology Business Overview
- 6.13.3 Yuensun Biological Technology Rhodiola Rosea P.E. Production, Value and Gross Margin (2021-2026)
- 6.13.4 Yuensun Biological Technology Rhodiola Rosea P.E. Product Portfolio
- 6.13.5 Yuensun Biological Technology Recent Developments
- 6.14 Xi'an Hao Tian
- 6.14.1 Xi'an Hao Tian Company Information
- 6.14.2 Xi'an Hao Tian Business Overview
- 6.14.3 Xi'an Hao Tian Rhodiola Rosea P.E. Production, Value and Gross Margin (2021-2026)
- 6.14.4 Xi'an Hao Tian Rhodiola Rosea P.E. Product Portfolio
- 6.14.5 Xi'an Hao Tian Recent Developments
- 6.15 Xi'an Gaoyuan
- 6.15.1 Xi'an Gaoyuan Company Information
- 6.15.2 Xi'an Gaoyuan Business Overview
- 6.15.3 Xi'an Gaoyuan Rhodiola Rosea P.E. Production, Value and Gross Margin (2021-2026)
- 6.15.4 Xi'an Gaoyuan Rhodiola Rosea P.E. Product Portfolio
- 6.15.5 Xi'an Gaoyuan Recent Developments
7 Global Rhodiola Rosea P.E. Production by Region
- 7.1 Global Rhodiola Rosea P.E. Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Rhodiola Rosea P.E. Production by Region (2021-2032)
- 7.2.1 Global Rhodiola Rosea P.E. Production by Region (2021-2026)
- 7.2.2 Global Rhodiola Rosea P.E. Production Forecast by Region (2027-2032)
- 7.3 Global Rhodiola Rosea P.E. Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Rhodiola Rosea P.E. Production Value by Region (2021-2032)
- 7.4.1 Global Rhodiola Rosea P.E. Production Value by Region (2021-2026)
- 7.4.2 Global Rhodiola Rosea P.E. Production Value by Region (2027-2032)
- 7.5 Global Rhodiola Rosea P.E. Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Rhodiola Rosea P.E. Production Value (2021-2032)
- 7.6.2 Europe Rhodiola Rosea P.E. Production Value (2021-2032)
- 7.6.3 Asia-Pacific Rhodiola Rosea P.E. Production Value (2021-2032)
- 7.6.4 South America Rhodiola Rosea P.E. Production Value (2021-2032)
- 7.6.5 Middle East & Africa Rhodiola Rosea P.E. Production Value (2021-2032)
8 Global Rhodiola Rosea P.E. Consumption by Region
- 8.1 Global Rhodiola Rosea P.E. Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Rhodiola Rosea P.E. Consumption by Region (2021-2032)
- 8.2.1 Global Rhodiola Rosea P.E. Consumption by Region (2021-2026)
- 8.2.2 Global Rhodiola Rosea P.E. Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Rhodiola Rosea P.E. Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Rhodiola Rosea P.E. Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Rhodiola Rosea P.E. Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Rhodiola Rosea P.E. Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Rhodiola Rosea P.E. Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Rhodiola Rosea P.E. Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Rhodiola Rosea P.E. Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Rhodiola Rosea P.E. Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Rhodiola Rosea P.E. Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Rhodiola Rosea P.E. Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Rhodiola Rosea P.E. Value Chain Analysis
- 9.1.1 Rhodiola Rosea P.E. Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Rhodiola Rosea P.E. Production Mode & Process
- 9.2 Rhodiola Rosea P.E. Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Rhodiola Rosea P.E. Distributors
- 9.2.3 Rhodiola Rosea P.E. Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst